These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37872022)

  • 21. Bivalirudin versus Heparin plus Glycoprotein IIb/IIIa Inhibitors in Women Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials.
    Xu H; Wang B; Yang J; Ma S; Xie X
    PLoS One; 2017; 12(1):e0169951. PubMed ID: 28095453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Outcomes of Bivalirudin Versus Heparin in Elderly Patients Undergoing Percutaneous Coronary Intervention: a Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Meng S; Xu J; Guo L; Huang R
    Cardiovasc Drugs Ther; 2020 Feb; 34(1):101-111. PubMed ID: 32100149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention in high-bleeding-risk patients with acute coronary syndrome in contemporary practice.
    Zhang Y; Zhang Y; Liu Z; Zhang B; Liu G; Chen K
    Biomed Pharmacother; 2020 Oct; 130():110758. PubMed ID: 34321166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bivalirudin Versus Heparin During PCI in NSTEMI: Individual Patient Data Meta-Analysis of Large Randomized Trials.
    Bikdeli B; Erlinge D; Valgimigli M; Kastrati A; Han Y; Steg PG; Stables RH; Mehran R; James SK; Frigoli E; Goldstein P; Li Y; Shahzad A; Schüpke S; Mehdipoor G; Chen S; Redfors B; Crowley A; Zhou Z; Stone GW
    Circulation; 2023 Oct; 148(16):1207-1219. PubMed ID: 37746717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of switching from unfractionated heparin to bivalirudin during primary percutaneous coronary intervention.
    Shah R; Jovin IS; Chaudhry A; Haji SA; Askari R; Dennis MM; Berzingi C; Rao SV
    Catheter Cardiovasc Interv; 2019 Feb; 93(2):241-247. PubMed ID: 30269393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bivalirudin versus heparin plus a glycoprotein IIb/IIIa inhibitor in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention after clopidogrel pretreatment: pooled analysis from the ACUITY and ISAR-REACT 4 trials.
    Ndrepepa G; Neumann FJ; Deliargyris EN; Mehran R; Mehilli J; Ferenc M; Schulz S; Schömig A; Kastrati A; Stone GW
    Circ Cardiovasc Interv; 2012 Oct; 5(5):705-12. PubMed ID: 23048052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial.
    Han Y; Guo J; Zheng Y; Zang H; Su X; Wang Y; Chen S; Jiang T; Yang P; Chen J; Jiang D; Jing Q; Liang Z; Liu H; Zhao X; Li J; Li Y; Xu B; Stone GW;
    JAMA; 2015 Apr; 313(13):1336-46. PubMed ID: 25775052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An updated comprehensive meta-analysis of bivalirudin vs heparin use in primary percutaneous coronary intervention.
    Shah R; Rogers KC; Matin K; Askari R; Rao SV
    Am Heart J; 2016 Jan; 171(1):14-24. PubMed ID: 26699596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of sex on comparative outcomes of bivalirudin versus unfractionated heparin in patients with acute coronary syndromes undergoing invasive management: a pre-specified analysis of the MATRIX trial.
    Gargiulo G; da Costa BR; Frigoli E; Palmieri C; Nazzaro MS; Falcone C; Liso A; Vigna C; Abate F; Comeglio M; Diletti R; Gabrielli G; Di Lorenzo E; Mazzarotto P; Zimarino M; Moretti C; Colombo A; Penzo C; Pasquetto G; Brugaletta S; Ferrari F; Casu G; Guiducci V; Dellavalle A; Liistro F; Mauro C; Van't Hof AWJ; Omerovic E; Curello S; de la Torre Hernandez JM; De Servi S; Belloni F; Windecker S; Valgimigli M
    EuroIntervention; 2019 Jun; 15(3):e269-e278. PubMed ID: 29769167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One-year clinical outcomes of bivalirudin versus unfractionated heparin in patients with type 2 diabetes undergoing elective percutaneous coronary intervention.
    Li Y; Li J; Guan C; Su S; Wang Z; Liu H; Yang Y; Gao R; Yuan J; Zhao X
    Diabetes Metab Syndr; 2023 Oct; 17(10):102858. PubMed ID: 37776692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of post-primary percutaneous coronary intervention bivalirudin infusion on net adverse clinical events and mortality: A comprehensive pairwise and network meta-analysis of randomized controlled trials.
    Shah R; Matin K; Rogers KC; Rao SV
    Catheter Cardiovasc Interv; 2017 Aug; 90(2):196-204. PubMed ID: 27862911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Safety and Efficacy of Unfractionated Heparin Versus Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention.
    Rehmani A; Judkins C; Whelan A; Nguyen M; Schultz C
    Heart Lung Circ; 2017 Dec; 26(12):1277-1281. PubMed ID: 28377232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bivalirudin Versus Heparin Monotherapy in ST-Segment-Elevation Myocardial Infarction.
    James S; Koul S; Andersson J; Angerås O; Bhiladvala P; Calais F; Danielewicz M; Fröbert O; Grimfjärd P; Götberg M; Henareh L; Ioanes D; Jensen J; Linder R; Lindroos P; Omerovic E; Panayi G; Råmunddal T; Sarno G; Ulvenstam A; Völtz S; Wagner H; Wikström H; Östlund O; Erlinge D
    Circ Cardiovasc Interv; 2021 Dec; 14(12):e008969. PubMed ID: 34903034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged High-Dose Bivalirudin Infusion Reduces Major Bleeding Without Increasing Stent Thrombosis in Patients Undergoing Primary Percutaneous Coronary Intervention: Novel Insights From an Updated Meta-Analysis.
    Fahrni G; Wolfrum M; De Maria GL; Banning AP; Benedetto U; Kharbanda RK
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27451466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transradial access mitigates bleeding benefit offered by bivalirudin over heparin in patients undergoing percutaneous coronary intervention: Insights from meta-analysis of randomized and observational studies.
    Pasala T; Gajulapalli RD; Bolen S; Bajaj NS; Gandhi S; Tandar A; Owan T; Welt FG
    Int J Cardiol; 2016 Oct; 221():601-8. PubMed ID: 27420586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis comparing bivalirudin versus heparin monotherapy on ischemic and bleeding outcomes after percutaneous coronary intervention.
    Bertrand OF; Jolly SS; Rao SV; Patel T; Belle L; Bernat I; Parodi G; Costerousse O; Mann T
    Am J Cardiol; 2012 Aug; 110(4):599-606. PubMed ID: 22591669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex-related response to bivalirudin and unfractionated heparin in patients with acute myocardial infarction undergoing percutaneous coronary intervention: A subgroup analysis of the VALIDATE-SWEDEHEART trial.
    Venetsanos D; Sederholm Lawesson S; Fröbert O; Omerovic E; Henareh L; Robertsson L; Linder R; Götberg M; James S; Alfredsson J; Erlinge D; Swahn E
    Eur Heart J Acute Cardiovasc Care; 2019 Sep; 8(6):502-509. PubMed ID: 30351167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of prehospital administration of unfractionated heparin, enoxaparin or bivalirudin in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Insights from the ORBI registry.
    Auffret V; Leurent G; Boulmier D; Bedossa M; Zabalawi A; Hacot JP; Coudert I; Filippi E; Castellant P; Rialan A; Rouault G; Druelles P; Boulanger B; Treuil J; Avez B; Le Guellec M; Gilard M; Le Breton H
    Arch Cardiovasc Dis; 2016 Dec; 109(12):696-707. PubMed ID: 27818120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in patients undergoing an invasive strategy: a meta-analysis of randomized clinical trials.
    Lee MS; Liao H; Yang T; Dhoot J; Tobis J; Fonarow G; Mahmud E
    Int J Cardiol; 2011 Nov; 152(3):369-74. PubMed ID: 20843568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention.
    Kastrati A; Neumann FJ; Mehilli J; Byrne RA; Iijima R; Büttner HJ; Khattab AA; Schulz S; Blankenship JC; Pache J; Minners J; Seyfarth M; Graf I; Skelding KA; Dirschinger J; Richardt G; Berger PB; Schömig A;
    N Engl J Med; 2008 Aug; 359(7):688-96. PubMed ID: 18703471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.